Shreya Life Sciences Private Limited, a active private limited company, was established on 10 April 1991 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51900MH1991PTC061136. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.80 Cr.
Formerly known as Amika Trading Pvt Ltd. It upholds a compliant status. Employing 1,169 professional, Its leadership includes Sujit Kumar Singh (Managing Director), Himanshu Baldev Singh (Whole-Time Director). Past directors included Sheel Kumar Dhananjay Singh, Radhe Krishan Nagpal, Bhavik Bhupendra Parekh. It holds ₹507.90 Cr open charges and ₹961.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shreya House 6Th Floor 301/A Pereira Hill Road Andheri East, Mumbai, Maharashtra, 400099.
U51900MH1991PTC061136
061136
10 April 1991
₹10.00 Cr
₹6.80 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shreya Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujit Kumar Singh | Managing Director | 30 Sep 1999 | Current |
| Himanshu Baldev Singh | Whole-Time Director | 01 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Mar 2019 | Past |
| Pramod Abcsdd | Alternate Director | 20 Mar 2009 | Past |
| Pramod Abcsdd | Company Secretary | 09 Dec 2019 | Past |
| Pramod Abcsdd | Company Secretary | 11 Aug 2011 | Past |
| Pramod Abcsdd | Company Secretary | 05 Oct 2007 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shreya Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 19.23% increase. The company also saw a substantial improvement in profitability, with a 35.61% increase in profit. The company's net worth moved up by a moderate rise of 2.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shreya Life Sciences had a promoter holding of 36.38% and a public holding of 63.62%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,079,000,000.00
₹9,618,302,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2025 | Others | ₹5.40 Cr | Open |
| 29 Jun 2024 | Others | ₹4.50 Cr | Open |
| 16 Aug 2013 | Open Joint Stock Company Promsvyazbank | ₹180.00 Cr | Open |
| 11 Jan 2012 | Open Joint Stock Company Promsvyazbank | ₹318.00 Cr | Open |
| 11 Mar 2024 | Indian Overseas Bank | ₹4.98 M | Satisfied |
Explore comprehensive loan charge details -
Shreya Life Sciences has a workforce of 1169 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shreya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreya Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 5.40 Cr with Charge ID 101082476 was registered on 29 Mar 2025. was documented.
A charge registered on 17 Jan 2017 via Charge ID 100075825 with Sbicap Trustee Company Limited was fully satisfied on 31 Dec 2024. was recorded as a recent event.
Progress on A charge registered on 11 Mar 2024 via Charge ID 100885250 with Indian Overseas Bank was fully satisfied on 10 Dec 2024. was documented.
The activity A charge registered on 08 Feb 2024 via Charge ID 100864509 with Indian Overseas Bank was fully satisfied on 10 Dec 2024. was completed.
The activity A charge registered on 27 Dec 2023 via Charge ID 100864520 with Indian Overseas Bank was fully satisfied on 10 Dec 2024. was completed.
The activity A charge registered on 01 Jul 2005 via Charge ID 80034405 with State Bank Of India was fully satisfied on 02 Dec 2024. was completed.
The acquisition deal between Aurobindo Pharma and Shreya Life Sciences for the latter's Russia business is potentially valued at $80 milllion to $100 million.
The CIN of Shreya Life Sciences Private Limited is U51900MH1991PTC061136.
Shreya Life Sciences Private Limited is headquartered at Shreya House 6Th Floor 301/A Pereira Hill Road Andheri East, Mumbai, Maharashtra, 400099.
Shreya Life Sciences Private Limited was incorporated on 10 April 1991.
The current directors of Shreya Life Sciences Private Limited are
The primary industry of Shreya Life Sciences Private Limited is Manufacturing.
Shreya Life Sciences Private Limited is unlisted.
The authorized capital of Shreya Life Sciences Private Limited is ₹10.00 Cr, and the paid-up capital is ₹6.80 Cr.
The compliance status of Shreya Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX